Pharma Industry News

Novo Nordisk’s massive operation in North Carolina getting even bigger

Written by David Miller

Danish diabetes drug maker Novo Nordisk is pumping an additional $65 million into the finished products plant in Clayton, North Carolina, even as it builds a $2 billion API facility there.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]